Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a protein boost stop muscle loss in the ICU?

NCT ID NCT06714240

First seen Jan 07, 2026 · Last updated Jun 23, 2026 · Updated 29 times

Summary

This study tests whether giving critically ill patients more protein in their tube feed (1.3 grams per kg of body weight per day, instead of the standard 0.8 grams) can help their muscles build protein and reduce wasting. Twenty-six adults on ventilators in the ICU will be randomly assigned to one of two protein levels. Muscle biopsies and blood samples will measure how well their muscles respond.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Jessa Hospital Campus Virga Jesse

    RECRUITING

    Hasselt, Limburg, 3500, Belgium

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

tube feed with higher protein levels

What this could lead to

If it works, this could point toward a simple nutritional strategy to reduce muscle wasting in critically ill patients.

What could go wrong

This is a very small, early-stage study (26 people) looking at lab markers, not clinical outcomes like strength or recovery. Results may not lead to a proven treatment.

Conditions

The condition(s) this trial relates to.

Critical Illness

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.